The 2007 ABJS Marshall Urist award: The impact of direct-to-consumer advertising in orthopaedics

Clinical Orthopaedics and Related Research

Volumn 458, Issue , 2007, Pages 202-219

  Bozic, Kevin J ^a,g   Smith, Amanda R ^a   Hariri, Sanaz ^b   Adeoye, Sanjo ^c   Gourville, John ^d   Maloney, William J ^e   Parsley, Brian ^f   Rubash, Harry E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HARVARD BUSINESS SCHOOL   (United States)

^e STANFORD UNIVERSITY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERTIZING; ARTICLE; CLINICAL PRACTICE; CONSUMER; FEMALE; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; KNEE ARTHROPLASTY; KNEE PROSTHESIS; MALE; ORTHOPEDICS; PATIENT SATISFACTION; PRIORITY JOURNAL; SURGEON; UNITED STATES; AWARDS AND PRIZES; DECISION MAKING; DOCTOR PATIENT RELATION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE DELIVERY; INFORMATION DISSEMINATION; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; PUBLIC OPINION; QUESTIONNAIRE;

ADVERTISING; AWARDS AND PRIZES; CONSUMER PARTICIPATION; DECISION MAKING; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INFORMATION DISSEMINATION; MALE; MARKETING OF HEALTH SERVICES; MIDDLE AGED; ORTHOPEDICS; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; PUBLIC OPINION; QUESTIONNAIRES;

EID: 34247885985     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e31804fdd02     Document Type: Article

References (27)

1. Aikin KJ, Swasy JL, Braman AC. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration, US Department of Health and Human Services; 2004.
2. Barber TC, Healy WL. The hospital cost of total hip arthroplasty: a comparison between 1981 and 1990. J Bone Joint Surg Am. 1993; 75:321-325.
3. Becker C. Skipping the hospital: implant campaign goes straight to the patient. Mod Healthc. 2003;33:16.
4. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14: 651-657.
5. Bell RA, Wilkes MS, Kravitz RL. Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. J Fam Pract. 1999;48:446-452.
6. Berry D, Harmsen WS, Cabanela ME, Morrey BF. Twenty-five year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular. J Bone Joint Surg Am. 2002;84:171-177.
7. Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J. Hospital resource utilization in primary and revision total hip arthroplasty. J Bone Joint Surg Am. 2005;87:570-576.
8. Callaghan JJ, Crowninshield RD, Greenwald AS, Lieberman JR, Rosenberg AG, Lewallen DG. Symposium: introducing technology into orthopaedic practice: how should it be done? J Bone Joint Surg Am. 2005;87:1146-1158.
9. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42:1176-1185.
10. Fehring TK, Mason JB. Catastrophic complications of minimally invasive hip surgery: a series of three cases. J Bone Joint Surg Am. 2005;87:711-714.
11. Findlay SD. Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers. Pharmacoeconomics. 2001;19:109-119.
12. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14:246-250.
13. Healy WL, Finn D. The hospital cost and the cost of the implant for total knee arthroplasty: a comparison between 1983 and 1991 for one hospital. J Bone Joint Surg Am. 1994;76:801-806.
14. Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA. 1999;281:380-382.
15. Holmer AF. Direct-to-consumer advertising: strengthening our health care system. N Engl J Med. 2002;346:526-528.
16. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293:1995-2002.
17. Labovitch RS, Bozic KJ, Hansen E. An evaluation of information available on the Internet regarding minimally invasive hip arthroplasty. J Arthroplasty. 2006;21:1-5.
18. Mendenhall S. Hip and Knee Implant Review. Birmingham. AL: Orthopedic Network News. 2006;2006:1-16.
19. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169:405-412.
20. National Institutes of Health. NIH consensus statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am. 2004; 86:1328-1335.
21. Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med. 2004;164:427-432.
22. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002; 346:498-505.
23. Soderman P, Malchau H, Herberts P. Outcome after total hip arthroplasty: part I: general health evaluation in relation to definition of failure in the Swedish National Total Hip Arthroplasty register. Acta Orthop Scand. 2000;71:354-359.
24. Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-219-33.
25. Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-82-95.
26. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-toconsumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358:1141-1146.
27. rd, Dalen JE, Jackson TR. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med. 2003;163:1808-1812.